Showing 1 - 4 results of 4 for search 'Michaël Doumen', query time: 0.03s Refine Results
  1. 1
    Treat-to-target fixed dose rituximab retreatment versus fixed interval retreatment with disease activity-guided rituximab dose optimisation for patients with rheumatoid arthritis: study protocol for a multicentre randomised controlled superiority trial focusing on long-term disease impact (RITUXERA)

    Treat-to-target fixed dose rituximab retreatment versus fixed interval retreatment with disease activity-guided rituximab dose optimisation for patients with rheumatoid arthritis:... by Elias De Meyst, Delphine Bertrand, Johan Joly, Michaël Doumen, Anja Marchal, Marc Thelissen, Barbara Neerinckx, René Westhovens, Patrick Verschueren

    Published 2024-10-01
    Get full text
    Article
  2. 2
    Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGORA)

    Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGOR... by Michaël Doumen, Elias De Meyst, Cedric Lefevre, Sofia Pazmino, Johan Joly, Delphine Bertrand, Mieke Devinck, René Westhovens, Patrick Verschueren

    Published 2023-10-01
    Get full text
    Article
  3. 3
    To flare or not to flare: patients’ and rheumatologists’ perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis

    To flare or not to flare: patients’ and rheumatologists’ perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis by Delphine Bertrand, Anke Deprez, Michaël Doumen, Diederik De Cock, Sofia Pazmino, Anja Marchal, Marc Thelissen, Johan Joly, Elias De Meyst, Barbara Neerinckx, René Westhovens, Patrick Verschueren

    Published 2024-02-01
    Get full text
    Article
  4. 4
    Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial

    Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, rando... by Piet Geusens, Laurent Meric de Bellefon, Patrick Durez, Ruth Wittoek, Luc De Clerck, Jan Lenaerts, René Westhovens, Kurt de Vlam, Marie Vanthuyne, Yves Piette, Isabelle Peene, Anne Durnez, Bert Vander Cruyssen, Sofia Ajeganova, Pauline Montigny, Sofia Pazmino, Johan Joly, Patrick Verschueren, Rik Joos, Christian von Frenckell, Clio Ribbens, Béatrice André, Michel Malaise, Delphine Bertrand, Luk Corluy, Veerle Taelman, Isabelle Ravelingien, Elke Geens, Johan Vanhoof, Els Van Essche, Barbara Neerinckx, Ioana Gofita, Elisa Docampo, Muriel Stubbe, Mieke Devinck, Bea Maeyaert, YVES BOUTSEN, Mihaela Maruseac, Michael Doumen, Alla Ishchenko, Stephanie Dierckx, Mark Walschot, Marie-Joëlle Kaiser, Philip Remans, Kristof Thevissen, Tom Zwaenepoel, Silvana Di Romana, Marc Vanden Berghe, Joëlle Margaux, Jan Van Offel, Elias De Meyst, Myroslava Kulyk, Nelly Creten, Anna Sileghem, Hubert Berghs, Marleen Coppens, Pascale Volders, Christine Langenaeken, Femke Meynen, Isabelle de Wergifosse, Caroline Verbist, Spyridon Kefalas, Celine Brasseur, Mihaela Sarbu, Charline Rinkin, Sandrine Halleux, Maria Jose Fernandez, Marijke Van Hoydonck, Bernard Bouchez, Catherine Naveau, Emmanuelle Caussin, Jean-Pol Dufour, Véronique Pauly, Kathleen Declerck, Stijn Michiels, Joke Vanderstukken, Evelien Deboeck, Anneleen Moeyersoons, Louis Van Praet, Gilles Blondiaux, Jean-Pierre Brasseur, Laure Tant, Muhammad Soyfoo

    Published 2024-08-01
    Get full text
    Article

Search Tools: